Journal of Medical Economics, Volume 19, Issue 4 (2016)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Journal of Medical Economics, Volume 19, Issue 4 (2016)

See all volumes and issues
Vol 27, 2024 Vol 26, 2023 Vol 25, 2022 Vol 24, 2021 Vol 23, 2020 Vol 22, 2019 Vol 21, 2018 Vol 20, 2017 Volume 19, 2016 Vol 18, 2015 Vol 17, 2014 Vol 16, 2013 Vol 15, 2012 Vol 14, 2011 Vol 13, 2010 Vol 12, 2009 Vol 11, 2008 Vol 10, 2007 Vol 9, 2006 Vol 8, 2005 Vol 7, 2004 Vol 6, 2003 Vol 5, 2002 Vol 4, 2001 Vol 3, 2000 Vol 2, 1999 Vol 1, 1998
Download citations Download PDFs Download issue

Respiratory

Article
Systematic review of models used in economic analyses in moderate-to-severe asthma and COPD
Thomas R. Einarson, Basil G. Bereza, T. Anders Nielsen, Jan Van Laer & Michiel E. H. Hemels
Pages: 319-355
Published online: 25 Feb 2016
AbstractforSystematic review of models used in economic analyses in moderate-to-severe asthma and COPD | Full Text | References | PDF (555.8 KB)
  • 1139 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Gastroenterology

Article
Cost-analysis model of colonoscopy preparation using split-dose reduced-volume oral sulfate solution (OSS) and polyethylene glycol with electrolytes solution (PEG-ELS)
Lynn Huynh, Sander Yermakov, Matthew Davis, Romaine Campbell, Mark Cleveland, Francis A. Farraye & Mihran Yenikomshian
Pages: 356-363
Published online: 21 Dec 2015
AbstractforCost-analysis model of colonoscopy preparation using split-dose reduced-volume oral sulfate solution (OSS) and polyethylene glycol with electrolytes solution (PEG-ELS) | Full Text | References | PDF (474.6 KB)
  • 591 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access

Hepatology

Article
Predictors of high healthcare resource utilization and liver disease progression among patients with chronic hepatitis C
Joyce LaMori, Neeta Tandon, François Laliberté, Guillaume Germain, Dominic Pilon, Patrick Lefebvre & Avinash Prabhakar
Pages: 364-373
Published online: 11 Jan 2016
AbstractforPredictors of high healthcare resource utilization and liver disease progression among patients with chronic hepatitis C | Full Text | References | PDF (269.5 KB)
  • 401 Views
  • 8 CrossRef citations
  • 0Altmetric
Free Access

Endocrinology

Article
Budget impact of pasireotide LAR for the treatment of acromegaly, a rare endocrine disorder
J. J. Zhang, D. Nellesen, W. H. Ludlam & M. P. Neary
Pages: 374-384
Published online: 12 Jan 2016
AbstractforBudget impact of pasireotide LAR for the treatment of acromegaly, a rare endocrine disorder | Full Text | References | PDF (1.7 MB)
  • 755 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access

Immunology

Article
Persistence, adherence, and all-cause healthcare costs in atazanavir- and darunavir-treated patients with human immunodeficiency virus in a real-world setting
Amanda M. Farr, Stephen S. Johnston, Corey Ritchings, Matthew Brouillette & Lisa Rosenblatt
Pages: 386-396
Published online: 29 Dec 2015
AbstractforPersistence, adherence, and all-cause healthcare costs in atazanavir- and darunavir-treated patients with human immunodeficiency virus in a real-world setting | Full Text | References | PDF (976.2 KB) | Supplemental
  • 541 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
A retrospective study of direct cost to patients associated with the use of oral oncology medications for the treatment of multiple myeloma
Claire Lee, Matthew Grigorian, Ryan Nolan, Gary Binder & Gary Rice
Pages: 397-402
Published online: 08 Jan 2016
AbstractforA retrospective study of direct cost to patients associated with the use of oral oncology medications for the treatment of multiple myeloma | Full Text | References | PDF (409.4 KB)
  • 964 Views
  • 16 CrossRef citations
  • 0Altmetric
Free Access

Diabetes

Article
Predictors of glycemic control and diabetes-related costs among type 2 diabetes patients initiating therapy with liraglutide in the United States
Emily Durden, Greg Lenhart, Lorena Lopez-Gonzalez, Mette Hammer & Jakob Langer
Pages: 403-413
Published online: 08 Jan 2016
AbstractforPredictors of glycemic control and diabetes-related costs among type 2 diabetes patients initiating therapy with liraglutide in the United States | Full Text | References | PDF (289.6 KB)
  • 1055 Views
  • 9 CrossRef citations
  • 0Altmetric
Free Access

Oncology

Article
Comparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2− metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysis
Nanxin Li, Yanni Hao, Valerie Koo, Anna Fang, Miranda Peeples, Andrew Kageleiry, Eric Q. Wu & Annie Guérin
Pages: 414-423
Published online: 01 Apr 2016
AbstractforComparison of medical costs and healthcare resource utilization of post-menopausal women with HR+/HER2− metastatic breast cancer receiving everolimus-based therapy or chemotherapy: a retrospective claims database analysis | Full Text | References | PDF (227.5 KB) | Supplemental
  • 1097 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

Hematology

Article
Pharmacoeconomics of ruxolitinib therapy in patients with myelofibrosis
Björn Vandewalle, Valeska Andreozzi, João Almeida & Jorge Félix
Pages: 424-431
Published online: 08 Jan 2016
AbstractforPharmacoeconomics of ruxolitinib therapy in patients with myelofibrosis | Full Text | References | PDF (438.2 KB)
  • 1586 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

Neurology

Article
Cost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis in the United States
Josephine Mauskopf, Monica Fay, Ravi Iyer, Sujata Sarda & Terrie Livingston
Pages: 432-442
Published online: 20 Jan 2016
AbstractforCost-effectiveness of delayed-release dimethyl fumarate for the treatment of relapsing forms of multiple sclerosis in the United States | Full Text | References | PDF (1.6 MB) | Supplemental
  • 1912 Views
  • 24 CrossRef citations
  • 0Altmetric
Free Access

Editorial

Editorial
JAK inhibitors truly changing the therapeutic paradigm in myelofibrosis
Claire N. Harrison
Pages: 443-444
Published online: 18 Feb 2016
CitationforJAK inhibitors truly changing the therapeutic paradigm in myelofibrosis | Full Text | References | PDF (172.6 KB)
  • 693 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Explore articles

Explore the most recently published articles

Intensive care unit improves dialysis care quality while reducing costs
Tara Greenleaf Nichols et al.
Research Letter | Published online: 7 Jun 2024
Open Access
The efficiency of TAVI in intermediate and low-risk Japanese patients
Panagiotis Petrou
Editorial | Published online: 7 Jun 2024
Open Access
Analysis of long-term clinical and cost impact of etranacogene dezaparvovec for the treatment of hemophilia B population in the United States
Songkai Yan et al.
Article | Published online: 6 Jun 2024
Open Access
Cost-effectiveness analysis of mosunetuzumab for treatment of relapsed or refractory follicular lymphoma after two or more lines of systemic therapy in the United States
Matthew Matasar et al.
Article | Published online: 6 Jun 2024
Open Access
View all latest articles